These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neurofibrillary axonal pathology in aluminum intoxication. Troncoso JC; Price DL; Griffin JW; Parhad IM Ann Neurol; 1982 Sep; 12(3):278-83. PubMed ID: 7137964 [No Abstract] [Full Text] [Related]
9. Aluminum: a possible neurotoxic agent in Alzheimer's disease. Crapper DR; Krishnan SS; De Boni U; Tomko GJ Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624 [No Abstract] [Full Text] [Related]
10. Aluminum and Alzheimer's disease. McLachlan DR Neurobiol Aging; 1986; 7(6):525-32. PubMed ID: 3550508 [TBL] [Abstract][Full Text] [Related]
11. Aluminum: a role in degenerative brain disease associated with neurofibrillary degeneration. McLachlan DR; Van Berkum MF Prog Brain Res; 1986; 70():399-410. PubMed ID: 3554357 [No Abstract] [Full Text] [Related]
12. Aluminum neurotoxicity and Alzheimer's disease. Still CN J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860 [No Abstract] [Full Text] [Related]
13. Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration. Crapper DR; Dalton AJ Physiol Behav; 1973 May; 10(5):925-33. PubMed ID: 4577243 [No Abstract] [Full Text] [Related]
14. Neurofibrillary pathology and aluminum in Alzheimer's disease. Shin RW; Lee VM; Trojanowski JQ Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016 [TBL] [Abstract][Full Text] [Related]
15. Aluminum and the central nervous system. Wisniewski HM; Sturman JA; Shek JW; Iqbal K J Environ Pathol Toxicol Oncol; 1985; 6(1):1-8. PubMed ID: 2415697 [No Abstract] [Full Text] [Related]
16. Neurofibrillary degeneration induced by systemic aluminum. Boni UD; Otvos A; Scott JW; Crapper DR Acta Neuropathol; 1976 Aug; 35(4):285-94. PubMed ID: 961381 [TBL] [Abstract][Full Text] [Related]
17. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Crapper DR; Dalton AJ Physiol Behav; 1973 May; 10(5):935-45. PubMed ID: 4736728 [No Abstract] [Full Text] [Related]
18. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease. Savory J; Huang Y; Wills MR; Herman MM Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes. MacDonald AB Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667 [TBL] [Abstract][Full Text] [Related]
20. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]